indications for glp-1 agonists GI Adverse Effects of Glucagon-Like Peptide-1 Receptor Frontiers | GLP−1 receptor agonists

There are eight types of GLP-1RAs commonly used in the domestic market in China, including three short-acting GLP-1RAs, exenatide, lisenatide, and benarutide, and a long-acting GLP-1RA, liraglutide

50,51,54 Early studies with dapagliflozin raised concerns about a potential increased incidence of bladder cancer

Trials demonstrating efficacy for weight loss and cardiovascular improvement have extended indications in relation to general obesity and cardiometabolic disease

Dual- and triple-receptor agonists acting via different receptors and postreceptor pathways seem attractive in view of potentially additive or synergistic effects in the treatment of T2D and obesity

How It Works Choose your Meds Order your medication online with just a few clicks

doi:10.1016/j.xcrm.2021.100263 60